Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | SAT1 | P21673 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14235689 | 0.98 | TSHR (0.59) | TSHRCYP2C19MEN1KMT2AGLA | |
| SCHEMBL22802794 | 0.98 | TSHR (0.59) | TSHRCYP2C19MEN1KMT2AGLA | |
| SCHEMBL15511439 | 0.93 | TSHR (0.59) | TSHRCYP2C19MEN1KMT2AGLA | |
| SCHEMBL13822687 | 0.92 | CYP2C19 (0.58) | TSHRCYP2C19MEN1KMT2AGLA | |
| SCHEMBL4810110 | 0.91 | TSHR (0.56) | TSHRCYP2C19MEN1KMT2AGLA | |
| SCHEMBL29174014 | 0.91 | TSHR (0.56) | TSHRCYP2C19MEN1KMT2AGLA | |
| SCHEMBL15511106 | 0.91 | TSHR (0.56) | TSHRCYP2C19MEN1KMT2AGLA | |
| SCHEMBL8979943 | 0.91 | TSHR (0.56) | TSHRCYP2C19MEN1KMT2AGLA | |
| SCHEMBL22848917 | 0.91 | TSHR (0.56) | TSHRCYP2C19MEN1KMT2AGLA | |
| SCHEMBL15510973 | 0.91 | TSHR (0.56) | TSHRCYP2C19MEN1KMT2AGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108693717-A | Anticorrosive additive stripping liquid controlling composition | 东友精细化工有限公司 | 2018-10-23 | — | — | CN | claimed |
| CN-103804980-A | Cleaning solution composition for offset-printing gravure and cleaning method using the same | DONGWOO FINE CHEM CO LTD | 2014-05-21 | — | — | CN | claimed |
| US-20230295180-A1 | PROTEIN DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-09-21 | — | — | US | disclosed |
| EP-2708529-B1 | METHOD FOR MANUFACTURING PARTICLES | SUMITOMO CHEMICAL CO (JP) | 2018-04-04 | — | — | EP | disclosed |
| US-9796831-B2 | Process for producing particles | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-24 | — | — | US | disclosed |
| US-20160296592-A1 | Methods and Compositions for the Treatment of Proteinuric Diseases | THE GENERAL HOSPITAL CORPORATION | 2016-10-13 | — | — | US | disclosed |
| CN-103974929-B | The manufacture method of the halogen acid salt of haloalkylamine | 住友化学株式会社 | 2016-08-24 | — | — | CN | disclosed |
| CN-103534236-B | Method for producing granules | 住友化学株式会社 | 2016-08-17 | — | — | CN | disclosed |
| CN-102850838-B | Offset printing intaglio plate cleaning liquid composition and the washing methods using said composition | TONGWOO FINE CHEMICALS CO., LTD. (KR) | 2016-01-13 | — | — | CN | disclosed |
| CN-103974929-A | Method for producing hydrohalic acid salt of halogenated alkyl amine | SUMITOMO CHEMICAL CO | 2014-08-06 | — | — | CN | disclosed |
| CN-103804980-A | Cleaning solution composition for offset-printing gravure and cleaning method using the same | DONGWOO FINE CHEM CO LTD | 2014-05-21 | — | — | CN | disclosed |
| EP-2708529-A1 | METHOD FOR MANUFACTURING PARTICLES | Sumitomo Chemical Company Limited (JP) | 2014-03-19 | — | — | EP | disclosed |
| US-20140065337-A1 | PROCESS FOR PRODUCING PARTICLES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-03-06 | — | — | US | disclosed |
| CN-103534236-A | Method for producing granules | SUMITOMO CHEMICAL CO | 2014-01-22 | — | — | CN | disclosed |
| CN-102850838-A | Intaglio washing solution composition used for offset printing and washing method using the same | DONGWOO FINE CHEM CO LTD | 2013-01-02 | — | — | CN | disclosed |
| CN-1312535-C | Optical photoresist stripping composition and cleaning composition | MITSUBISHI GAS CHEMICAL CO (JP) | 2007-04-25 | — | — | CN | disclosed |
| CN-1444103-A | Optical photoresist stripping composition and cleaning composition | MITSUBISHI GAS CHEMICAL CO (JP) | 2003-09-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160296592-A1 | Methods and Compositions for the Treatment of Proteinuric Diseases | ITGB3, PLAUR, PROC | TSHR 2924/4885CYP2C19 4008/4885MEN1 3989/4885 |
| US-20230295180-A1 | PROTEIN DEGRADERS AND USES THEREOF | MDM2, CUL1, PSMG3 | TSHR 3432/4885CYP2C19 3642/4885MEN1 2643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.